Current drug development strategies take one or a few rigid structure(s) of an individual protein and design a single molecule to block its activity (i.e., catalytic pocket).

We are developing a more sophisticated methodology that exploits flexible target structures, allosteric pocket identification and evolutionary analysis. Merging these new methods represents an important advance that will greatly facilitate the design of selective inhibitors.

Read More...

Tags: drug_discovery